Coronary Artery Bypass Graft (CABG) Procedures Market | Size, Share, Industry Growth | 2024 to 2032

A detailed analysis of the Global Coronary Artery Bypass Graft (CABG) Procedures Market 2024 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share, competitive landscape, sales analysis, impact of domestic and global Coronary Artery Bypass Graft (CABG) Procedures Market players, value chain optimization, trade regulations, recent developments, strategic market growth analyses, product launches, expanding the area market, and technological advances.

The report offers a comprehensive analysis of Coronary Artery Bypass Graft (CABG) Procedures, encompassing factors such as growth rate, market share, size, current and emerging trends, production and consumption ratios, industrial chain dynamics, demand and supply metrics, import and export trends, revenue contribution, and the presence of key players. The analysis is segmented into key global regions. Additionally, the report includes a detailed country-by-country analysis to provide a clearer understanding of the regional distribution and growth of the Coronary Artery Bypass Graft (CABG) Procedures market.

Request a sample report of Coronary Artery Bypass Graft (CABG) Procedures Market @

Market Overview:

The global market size for Coronary Artery Bypass Graft (CABG) procedures amounted to USD 7.2 billion in 2022 and is projected to reach USD 12.3 billion by 2032, reflecting a steady revenue compound annual growth rate (CAGR) of 6.1% over the forecast period. Key drivers fueling the expansion of market revenue include the increasing prevalence of Cardiovascular Diseases (CVDs), particularly Coronary Artery Disease (CAD), and the growing elderly population. The market’s growth is further propelled by a heightened demand for less invasive surgical procedures and advancements in both surgical methods and equipment.

Coronary artery disease (CAD), a pervasive form of cardiovascular disease, is triggered by the accumulation of plaque in the arteries that supply blood to the heart. Although Coronary Artery Bypass Graft (CABG) surgeries stand out as highly effective treatments for CAD, the prevalence of CAD is expected to rise. Additionally, as the risk of developing CAD and other cardiovascular ailments increases with age, the expansion of the market is anticipated to be facilitated by the growing elderly population.

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Strategic Development:

  • On 6 December 2017, Edwards Lifesciences Corporation announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company that develops minimally invasive mitral valve repair technology. The acquisition was aimed at expanding Edwards Lifesciences’ product offerings in the structural heart disease market.
  • On 3 September 2021, Abbott Laboratories announced the acquisition of Walk Vascular, LLC, a Medical Device company that develops minimally invasive solutions for the treatment of peripheral artery disease. The acquisition was aimed at expanding Abbott Laboratories’ product portfolio in the peripheral artery disease market.
  • On 20 August 2019, Boston Scientific Corporation announced the acquisition of BTG plc, a healthcare company that develops and commercializes products used in the treatment of cancer and vascular conditions. The acquisition was aimed at expanding Boston Scientific’s product offerings in the interventional medicine market.

Key Players covered in this report are

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • HeartWare International, Inc.
  • MAQUET Holding B.V. & Co. KG
  • Medtronic plc
  • Sorin Group
  • St. Jude Medical, Inc.
  • Swissray Global Healthcare Holding, Ltd.
  • Teleflex Incorporated

Procedure Type Outlook (Revenue, USD Billion; 2019-2032)

  • Traditional CABG
  • Off-pump CABG
  • Minimally Invasive CABG

End-use Outlook (Revenue, USD Billion; 2019-2032)

  • Hospitals
  • Ambulatory Surgical Centers

Read the full report @

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Coronary Artery Bypass Graft (CABG) Procedures industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Coronary Artery Bypass Graft (CABG) Procedures manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Explore additional Reports:

Bioreactors and Fermenters Market @

Soft Ferrite Core Market @

Hydroxypropyl Starch Ether Market @

Latex Powder Market @

Aroma Chemicals Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370


Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @